Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data & AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma & Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
Subscribe
Subscribe

False

The Analytical Scientist / Authors / Michael Snyder

Michael Snyder

Michael Snyder is a Stanford Ascherman professor, the chair of the department of genetics and director of the Stanford Center for Genomics and Personalized Medicine, Stanford University, California, USA. He received his Ph.D. training at the California Institute of Technology and carried out his postdoctoral training at Stanford University. He is recognized internationally for major contributions that have revolutionized the field of genetics. He launched the first large-scale characterization of eukaryotic genes using a transposon tagging strategy. He is a co-inventor of Chip-chip and Chip-seq as well as the first chromosome tiling arrays. Snyder is also the inventor of RNA-Seq and paired-end sequencing for eukaryotic cells using high-throughput sequencing methods. Recently, he performed the first detailed longitudinal integrative personal omics profile (iPOP) of a person and used this information to assess disease risk and monitor disease states for personalized medicine.

  • Contributions
Techniques & Tools Omics

There’s More to Life Than DNA

September 15, 2015

Genomics often steals the headlines, but could metabolomics be the true deliverer of personalized medicine?

1 min read

There’s More to Life Than DNA

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.